Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Finasteride,Tadalafil
Therapeutic Area : Urology
Study Phase : Approved
Sponsor : Blue Water Vaccines
Deal Size : Undisclosed
Deal Type : Acquisition
Details : The combined company will focus on the R&D and commercialization of proprietary science and technologies for therapeutics, including Entadfi, a once-daily, oral treatment for BPH that combines finasteride, a 5α-reductase inhibitor, and tadalafil, a PDE5...
Brand Name : Entadfi
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 18, 2023
Lead Product(s) : Finasteride,Tadalafil
Therapeutic Area : Urology
Highest Development Status : Approved
Sponsor : Blue Water Vaccines
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?